Save
www.world-stroke.org
Should thrombectomy be used in mild stroke?
World Stroke Academy, Pooja Khatri & Shelagh Coutts, 259715
Post-stroke fatigue and physical inactivity
World Stroke Academy, Gillian Mead, 234639
Should thrombectomy be used in mild stroke? - CON
World Stroke Academy, Shelagh Coutts, 234104
Should thrombectomy be used in mild stroke? - PRO
World Stroke Academy, Pooja Khatri, 234103
IMAGING OF ACUTE INTRACEREBRAL HAEMORRHAGE - WHEN TO GO BEYOND CT/CTA
World Stroke Academy, Chitra Venkatasubramanian, 234097
Establishing acute stroke care pathways in resource poor systems of health care
World Stroke Academy, Vasantha Padma, 234073
Part 5: How to do health services research in stroke: A focus on performance measurement and quality improvement
World Stroke Academy, Dominique A Cadilhac, 228086
Post stroke fatigue: Low recognition, high impact
World Stroke Academy, M. Patrice Lindsay, 233816
Part 4: Design and implementation of observational studies to measure disease burden with a focus on stroke
World Stroke Academy, George Howard, 228085
Part 3: How to do a systematic review
World Stroke Academy, Alex Pollock, 228082
Part 2: Clinical stroke research in resource limited settings - tips and hints
World Stroke Academy, Jeyaraj Pandian and Richard Lindley, 228079
How to do good quality clinical research
World Stroke Academy, Peter Sandercock, 228078
When should robotics be used in stroke patients?
World Stroke Academy, Andreas Mayr, 226291
How to recognise a patient suitable for hemicraniectomy?
World Stroke Academy, Eric Juettler, 226639
What are the most important outcomes of motor rehabilitation after stroke?
World Stroke Academy, Jan Mehrholz, 219714
Post-Stroke Dysphagia
World Stroke Academy, Michaela Trapl-Grundschober, 219420
Post-Stroke Dysphagia Chapters
World Stroke Academy, Michaela Trapl-Grundschober, 219421
Mechanical Thrombectomy
World Stroke Academy, Prof. Diederik Dippel & Dr. Bart Emmer, 210952
Mobile stroke units
World Stroke Academy, Stephen Davis, Geoffrey Donnan, Silke Walter, 208056
How to recognise body neglect in a stroke patient?
World Stroke Academy, Thomas Benke, 204328
What are the main benefits and side effects of New Oral Anticoagulants?
World Stroke Academy, Hans Christoph Diener, 203945
What are the most frequent Posterior Circulation Syndromes?
World Stroke Academy, Patrik Michel, 203897
How to recognise stroke mimics in the acute setting
World Stroke Academy, Patrik Michel, 203694
Intravenous thrombolysis in acute stroke
World Stroke Academy, Ana Catarina Fonseca & Daniel Strbian, 203691
Case studies
World Stroke Academy, Ana Catarina Gaspar Fonseca, 203692
Intravenous thrombolysis in acute stroke
World Stroke Academy, Course Faculty, 203693
Organización de las redes asistenciales de Ataque CerebroVascular
World Stroke Academy, Sheila C. O. Martins & Daissy Liliana Mora Cuervo, 203255
Novel oral anticoagulant management issues for the stroke clinician
World Stroke Academy, Ken Butcher, 203112
Case studies
World Stroke Academy, Andrew Wassef & Ken Butcher, 203113
NOACs
World Stroke Academy, Course Faculty, 203114
Epidemiología del Ataque Cerebrovascular: Panorama Latinoamericano
World Stroke Academy, Pablo Lavados, 198864
Protocolo de atención del Ataque Cerebrovascular Agudo y Unidad de ACV agudo
World Stroke Academy, Sheila Martins, 198959
Managing a stroke unit in a rural African setting
World Stroke Academy, Alan Bryer, 193083
How to manage hypertension in the acute phase?
World Stroke Academy, Natan Bornstein, 199291
Rapid imaging. Rapid diagnosis.
World Stroke Academy, Patrik Michel, 199292
How do you consider diabetes treatment after a stroke?
World Stroke Academy, Jaakko Tuomilehto, 199293
GENERAL OR LOCAL ANESTHESIA IN INTRA ARTERIAL THERAPY (”GOLIATH”): A RANDOMIZED TRIAL
World Stroke Academy, Claus Simonsen, 183417
THE ANSTROKE TRIAL
World Stroke Academy, Pia Hendén, 183412
PRASUGREL VERSUS CLOPIDOGREL IN ISCHEMIC STROKE PATIENTS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP TRIAL (THE PRASTRO-I)
World Stroke Academy, Kazunori Toyoda, 183419
MILD STROKE DUE TO LARGE ARTERY OCCLUSION. WHEN IS IV THROMBOLYSIS NOT ENOUGH? RESULTS FROM THE SITS-ISTR REGISTRY
World Stroke Academy, Michael Mazya, 183415
LONG-TERM ANTITHROMBOTIC TREATMENT IN INTRACRANIAL HEMORRHAGE SURVIVORS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
World Stroke Academy, Eleni Korompoki, 183413
RESUMPTION OF ORAL ANTICOAGULATION AFTER INTRACEREBRAL HEMORRHAGE IS ASSOCIATED WITH DECREASED MORTALITY AND FAVORABLE FUNCTIONAL OUTCOME
World Stroke Academy, Joji Kuramatsu, 183414
Early Prolonged Ambulatory Cardiac Monitoring in Stroke (EPACS): Randomised Clinical Trial using patch-based cardiac monitoring
World Stroke Academy, James Teo, 183418
COMPARING THE IMPACT OF BASELINE COLLATERAL STATUS ASSESSED BY DIFFERENT COLLATERAL SCORES AND IMAGING MODALITIES ON OUTCOMES IN ACUTE ISCHEMIC PATIENTS: META-ANALYSIS FROM THE HERMES-COLLABORATION
World Stroke Academy, Henrik Gensicke, 183411
RISK FACTORS FOR DELIRIUM AND COGNITIVE IMPAIRMENT AFTER STROKE
World Stroke Academy, Sarah Pendlebury, 183406
ROLE OF AMYLOID IMAGING IN POST-STROKE MCI AND DEMENTIA
World Stroke Academy, Vincent CT Mok, 183405
CAA-RELATED COGNITIVE IMPAIRMENT: CLINICAL FEATURES AND MECHANISMS
World Stroke Academy, David J Werring, 183408
THE NEUROBIOLOGY OF VASCULAR DEMENTIA
World Stroke Academy, Costantino Iadecola , 183404
CHOLESTEROL: HOW LOW SHOULD WE GO, AND HOW?
World Stroke Academy, George Ntaios, 183400
ANTI-PLATELET DRUGS: WHY DO WE STILL USE ASPIRIN?
World Stroke Academy, Ale Algra, 183398
AIR POLLUTION AND RISK OF STROKE
World Stroke Academy, Valery Feigin, 183392
THE STROKE ROAD MAP
World Stroke Academy, M. Patrice Lindsay, 183393
LESSONS FROM INTERSTROKE
World Stroke Academy, Martin O’Donnell, 183395
STROKE AND POVERTY
World Stroke Academy, Bo Norrving, 183394
HOW TO ORGANIZE YOUR STROKE CENTER AND STROKE NETWORK
World Stroke Academy, Mayank Goyal, 183386
ENDOVASCULAR STROKE TREATMENT BEYOND GUIDELINES: A PLEA FOR THE PATIENT
World Stroke Academy, Jan Gralla, 183387
PRE-HOSPITAL SELECTION FOR ENDOVASCULAR TREATMENT
World Stroke Academy, Urs Fischer, 183385
ENDOVASCULAR TREATMENT OF ISCHEMIC STROKE: CURRENT EVIDENCE
World Stroke Academy, Pooja Khatri, 183388
OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF EIGHT TRIALS
World Stroke Academy, Werner Hacke, 183377
TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET
World Stroke Academy, Svetlana Lorenzano, 183380
PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY
World Stroke Academy, Bruce Campbell, 183374
TALOS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO TEST THE VASCULAR AND NEUROPROTECTIVE EFFECTS OF CITALOPRAM IN PATIENTS WITH ACUTE ISCHEMIC STROKE
World Stroke Academy, Kristian Lundsgaard Kraglund, 183379
THROMBOLYSIS OR ANTICOAGULATION FOR CEREBRAL VENOUS THROMBOSIS (TO-ACT): A RANDOMISED CONTROLLED TRIAL
World Stroke Academy, Jonathan Coutinho, 183375
THE NORWEGIAN TENECTEPLASE STROKE TRIAL (NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN ACUTE ISCHAEMIC STROKE
World Stroke Academy, Nicola Logallo, 183367
CONTACT ASPIRATION VERSUS STENT RETRIEVER FRONT- LINE FOR RECANALISATION IN ACUTE CEREBRAL INFARCTION: THE ASTER TRIAL
World Stroke Academy, Bertrand Lapergue, 183365
THE T3 TRIAL: TRIAGE, TREATMENT AND TRANSFER OF PATIENTS WITH STROKE IN EMERGENCY DEPARTMENTS
World Stroke Academy, Sandy Middleton, 183369
EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)
World Stroke Academy, Femke Nouwens, 183371
DAWN in full daylight (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention)
World Stroke Academy, Raul Nogueira, 183370
PFO Closure in the Gore REDUCE Clinical Trial: Primary Results
World Stroke Academy, Scott E. Kasner, 183364
CLOSURE OF PATENT FORAMEN OVALE, ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE (CLOSE): A RANDOMIZED CLINICAL TRIAL
World Stroke Academy, Jean-Louis Mas, 183368
Official Welcome & Large Clinical Trials: Convenor
World Stroke Academy, Robert Mikulik, 183363
Official Welcome & Large Clinical Trials: Convenor
World Stroke Academy, Martin Dichgans, 183362
What to do when I find resistant bacteria on my ward?
World Stroke Academy, Achim Kaasch, 182302
Assessment & Evaluation
World Stroke Academy, Julian Bösel, 188672
Main neuropathological features
World Stroke Academy, Kurt Jellinger, 170314
When is multimodal imaging necessary?
World Stroke Academy, Jens Fiehler, 170247
Neurosonology and Pharmacology
World Stroke Academy, Laszlo Csiba, 166166
Management of TIA
World Stroke Academy, Peter Sandercock, 154838
Investigation of TIA
World Stroke Academy, Peter Sandercock, 154837
Clinical Assessment of TIA
World Stroke Academy, Peter Sandercock, 154836
Introduction
World Stroke Academy, Peter Sandercock, 150371
Why are TIAs important
World Stroke Academy, Peter Sandercock, 150372
TIA
World Stroke Academy, Peter Sandercock, 184709
PRO - WE SHOULD OPERATE ON MORE PATIENTS
World Stroke Academy, Girish Menon, 154555
CON - THE POLYPILL IS ENOUGH
World Stroke Academy, Jayanta Roy, 154554
PRO - PREVENTION MUST BE TARGETED
World Stroke Academy, Hans Christoph Diener, 154553
USING GENETICS TO PREDICT STROKE RISK: IS IT USEFUL NOW AND WILL IT BE IN THE FUTURE?
World Stroke Academy, Sudha Seshadri, 154552
IS GENETICS IMPORTANT FOR STROKE IN AFRICA?
World Stroke Academy, Rufus Akinyemi, 154551
INTRACEREBRAL HAEMORRHAGE: WHAT DO RECENT GENETIC STUDIES TELL THE PRACTICING CLINICIAN?
World Stroke Academy, Sudha Seshadri, 154550
TELESTROKE IN INDIA
World Stroke Academy, Vasantha Padma, 154548
TELESTROKE IN DEVELOPING COUNTRIES
World Stroke Academy, Sombat Muengtaweepongsa, 154547
THE TELESTROKE UNIT CONCEPT: MAKING EVIDENCE BASED STROKE MANAGEMENT AVAILABLE IN UNDERSERVED AREAS WORLDWIDE?
World Stroke Academy, Heinrich Audebert, 154546
HYPERTENSION IN STROKE IN ASIA
World Stroke Academy, Jong S. Kim, 154545
BP MANAGEMENT IN THE ACUTE STROKE
World Stroke Academy, Craig Anderson, 154544
GLOBAL BURDEN OF STROKE: HYPERTENSION AT THE CORE
World Stroke Academy, Daniel Lackland, 154543
WHAT WILL THE NEXT BIG ADVANCE BE?
World Stroke Academy, Werner Hacke, 154538
PHARMACOLOGICAL APPROACHES OF EMOTIONAL AND BEHAVIORAL DISORDERS AFTER STROKE
World Stroke Academy, Jong S. Kim, 154542
INTRA CEREBRAL HAEMORRHAGES: CAN WE STOP THEM BLEEDING?
World Stroke Academy, Andrew Demchuk, 154537
RELATIONSHIP BETWEEN POST STROKE FATIGUE AND DEPRESSION
World Stroke Academy, M. Patrice Lindsay, 154541
THROMBOLYSIS: CAN WE DO BETTER?
World Stroke Academy, Stephen M. Davis, 154536

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings